370
Views
11
CrossRef citations to date
0
Altmetric
Review

Tranexamic acid for childbirth: why, when, and for whom

, , , , , & show all
Pages 753-761 | Received 02 Apr 2019, Accepted 09 Jul 2019, Published online: 05 Aug 2019

References

  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–e333.
  • Sentilhes L, Vayssière C, Deneux-Tharaux C, et al. Postpartum hemorrhage: guidelines for clinical practice from the French college of gynaecologists and obstetricians (CNGOF) in collaboration with the French society of anesthesiology and intensive care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12–21.
  • Sentilhes L, Merlot B, Madar H, et al. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043–1061.
  • Mavrides E, Allard S, Chandraharan E, et al. On behalf of the Royal college of obstetricians and gynaecologists. Prevention and management of postpartum haemorrhage. BJOG. 2016;124:e106–e149.
  • Committee on Practice Bulletins-Obstetrics. Practice bulletin No. 183: postpartum hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168–e186.
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of postpartum hemorrhage. 2011 Mar cited 2018 Mar 1. Available from: http://www.ranzcog.edu.au/collegestatements-guidelines.html
  • Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31:980–993.
  • WHO recommendations for the prevention of postpartum haemorrhage. World Health Organisation. Geneva (Switzerland); 2012 cited 2019 Mar 1. Available from: http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf
  • FIGO safe motherhood and newborn health (SMNH) committee. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynecol Obstet. 2012;117:108–118.
  • Sentilhes L, Goffinet F. Vayssière C., et al. Comparison of postpartum haemorrhage guidelines: discrepancies underline our ignorance. BJOG. 2017;124:718–722.
  • Begley CM, Gyte GM, Devane D, et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2015;3:CD007412.
  • Sentilhes L, Lasocki S, Ducloy-Bouthors AS, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2015;114:576–587.
  • Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266–273.
  • Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108:984–989.
  • Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.
  • Myles PS, Smith JA, Forbes A, et al. ATACAS Investigators of the ANZCA clinical trials network. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017 Jan 12;376(2):136–148.
  • CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.
  • Matteson KA, Rahn DD, Wheeler TL 2nd, et al. Society of gynecologic surgeons systematic review group. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013;121:632–643.
  • WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–2116.
  • Sentilhes L, Winer N, Azria E, et al. For the Groupe de Recherche en Obstétrique et Gynécologie (GROG). Tranexamic acid for the prevention of blood loss after vaginal delivery. N Engl J Med. 2018;379:731–742.
  • Ducloy-Bouthors AS, Jude B, Duhamel A, et al. EXADELI study group, Susen S. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15:R117.
  • Bouet PE, Ruiz V, Legendre G, et al. High-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery. Brit J Anaesth. 2015;114:339–341.
  • Bouet PE, Ruiz V, Legendre G, et al. Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery. J Matern Fetal Neonatal Med. 2015;29:1–6.
  • [cited 2012 Mar 07]. Available from: http://spiral.univ-lyon1.fr/files_m/M11263/Files/897436_1562.pdf
  • Chugh KS, Jha V, Sakhuja V, et al. Acute renal cortical necrosis–a study of 113 patients. Ren Fail. 1994;16(1):37–47.
  • Jonard M, Ducloy-Bouthors AS, Boyle E, et al. Postpartum acute renal failure: a multicenter study of risk factors in patients admitted to ICU. Ann Intensive Care. 2014;4:36.
  • Frimat M, Decambron M, Lebas C, et al. Renal cortical necrosis in postpartum hemorrhage: a case series. Am J Kidney Dis. 2016;68:50–57.
  • Meibody F, Jamme M, Tsatsaris V, et al. Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers. Nephrol Dial Transplant. 2019 Feb 25;gfz025. DOI:10.1093/ndt/gfz025
  • Keyl C, Uhl R, Beyersdorf F, et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2011;39:e114–121.
  • Sentilhes L, Goffinet F, Deneux-Tharaux C. Is it time to clearly discourage prolonged administration of tranexamic acid to treat postpartum hemorrhage? Am J Kidney Dis. 2017;69:160.
  • [cited 2019 Jul 24]. Available from: https://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/EXACYL-R-0-5-g-5-ml-I.V.-solution-injectable-acide-tranexamique-Mises-en-gardes-sur-le-risque-potentiel-d-atteinte-renale-aigue-en-cas-d-utilisation-de-doses-superieures-a-2-g-doses-totales-dans-les-Hemorragies-du-Post-Partum-HPP-Lettre-aux-professionnels-de-sante
  • Ducloy-Bouthors AS, Duhamel A, Kipnis E, et al. Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth. 2016;116:641–648.
  • Shakur-Still H, Roberts I, Fawole B, et al. Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial. Wellcome Open Res. 2018 Aug 15;3:100.
  • Dennis AT, Griffiths JD. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet. 2017 Sep 30;390(10102):1582.
  • Letson HL, Dobson GP. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet. 2017 Sep 30;390(10102):1581–1582.
  • Pacheco LD, Hankins GDV, Saad AF, et al. Tranexamic acid for the management of obstetric hemorrhage. Obstet Gynecol. 2017;130:765–769.
  • Butwick A, Deneux-Tharaux C, Sentilhes L. Tranexamic acid for the management of obstetric hemorrhage. Obstet Gynecol. 2017;130:1386.
  • Dobson GP, Doma K, Letson HL. Clinical relevance of a p value: does tranexamic acid save lives after trauma or postpartum hemorrhage? J Trauma Acute Care Surg. 2018 Mar;84(3):532–536.
  • Gillissen A, Henriquez DDCA, van Den Akker T, et al. The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: A nationwide retrospective cohort study. PLoS One. 2017;12:e0187555.
  • Gayet-Ageron A, Prieto-Merino D, Ker K, et al. For the anti-fibrinolytic trials collaboration. Impact of treatment delay on the effectiveness and safety of anti-fibrinolytics in acute severe haemorrhage: an individual patient data meta-analysis in 40,138 bleeding patients. Lancet. 2018;391:125–132.
  • World Health Organization. Summary of the report of the 18th meeting of the WHO expert committee on the selection and use of essential medicines. Accra, Ghana: WHO Press; 2011 Mar 21–25. Available from: http://www.who.int/selection_medicines/committees/expert/18/en/index.html
  • WHO. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. Geneva: World Health Organization; 2017.
  • Vogel JP, Oladapo OT, Dowswell T, et al. Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage. Lancet Glob Health. 2018;6:e18–e19.
  • Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi. 2001;36:590–592.
  • Gungorduk K, Asıcıoğlu O, Yıldırım G, et al. Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. Am J Perinatol. 2013;30:407–413.
  • Mirghafourvand M, Mohammad-Alizadeh S, Abbasalizadeh F, et al. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial. Aust N Z J Obstet Gynaecol. 2015;55:53–58.
  • Gai M, Wu L, Su Q, et al. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112:154–157.
  • Gohel M, Patel P, Gupta A, et al. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: arandomised case controlled prospective study. J Obstet Gynecol India. 2007;57:227–230.
  • Sekhavat L, Tabatabaii A, Dalili M, et al. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med. 2009;22:72–75.
  • Gungorduk K, Yıldırım G, Asıcıoğlu O, et al. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol. 2011;28:233–240.
  • Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet. 2011;115:224–226.
  • Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet. 2013;287:463–468.
  • Sentürk MB, Cakmak Y, Yildiz G, et al. Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet. 2013;287:641–645.
  • Shahid A, Khan A. Tranexamic acid in decreasing blood loss during and after caesarean section. J Coll Physicians Surg–Pak JCPSP. 2013;23:459–462.
  • Abdel-Aleem A, Alhusaini TK, Abdel-Aleem MA, et al. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Fetal Neonatal Med. 2013;26:1705–1709.
  • Gobbur V, Shiragur S, Jhanwar U, et al. Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section. Int J Reprod Contracept Obstet Gynecol. 2014;3:414–417.
  • Halder S, Samanta B, Sardar R, et al. Tranexamic acid used before caesarean section reduces blood loss based on pre- and postoperative haemaoglobin level: a case-control study. J India Med Assoc. 2013;111:184–186.
  • Ahmed MR, Sayed Ahmed WA, Madny EH, et al. Efficacy of tranexamic acid in decreasing blood loss in elective caesarean delivery. J Matern Fetal Neonatal Med. 2015;28:1014–1018.
  • Goswami U, Sarangi S, Gupta S, et al. Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial. Saudi J Anaesth. 2013;7:427–431.
  • Yehia AH, Koleib MH, Abdelazim IA, et al. Tranexamic acid reduces blood loss during and after cesarean section: a double blinded,randomized, controlled trial. Asian Pac J Reprod. 2014;3:53–56.
  • Maged AM, Helal OM, Elsherbini MM, et al. A randomized placebo controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. Int J Gynaecol Obstet. 2015;131:265–268.
  • Sujata N, Tobin R, Kaur R, et al. Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. Int J Gynaecol Obstet. 2016;133:312–315.
  • Sentilhes L, Daniel V, Darsonval A, et al. Study protocol. TRAAP – tRAnexamic acid for preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial. BMC Pregnancy Childbirth. 2015;15:135.
  • Ker K, Shakur H, Roberts I. Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials. BJOG. 2016 Oct;123(11):1745–1752.
  • Sentilhes L, Merlot B, Brun S, et al. Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials: A publication very welcome. BJOG. 2017;124:982.
  • Sentilhes L, Brun S, Madar H, et al. Tranexamic acid for preventing postpartum blood loss at cesarean delivery: is evidence sufficient? Acta Obstet Gynecol Scand. 2016;95:836.
  • Sentilhes L, Brun S, Madar H, et al. Tranexamic acid for prevention PPH: a promising drug but today only a promising drug. Transfus Med Rev. 2016;30:100.
  • Sentilhes L, Deneux-Tharaux C. Prophylactic tranexamic acid in addition to uterotonics may prevent blood loss in vaginal and caesarean deliveries. Evidence Based Med. 2016;21:97.
  • Alam A, Choi S. Prophylactic use of tranexamic acid for postpartum bleeding outcomes: a systematic review and meta-analysis of randomized controlled trials. Transfus Med Rev. 2015;29:231–241.
  • Shakur-Still H, Roberts I. Finding better ways to prevent postpartum hemorrhage. N Engl J Med. 2018;379:790–792.
  • Li C, Gong Y, Dong L, et al. Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention? A systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e5653.
  • Kamel H, Navi BB, Sriram N, et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–1315.
  • Walzman M, Bonnar J. Effect of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. Arch Toxicol Suppl. 1982;5:214–220.
  • Eriksson O, Kjellman H, Nilsson L. Tranexamic acid in human milk after oral administration of Cyklokapron to lactating women. Stockholm (Sweden): KabiVitrum AB; 1971. Data on file.
  • Gilad O, Merlob P, Stahl H, et al. Outcome following tranexamic acid exposure during breastfeeding. Breastfeed Med. 2014;9:407–410.
  • Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl. 1980;14:41–47.
  • Wesley MC, Pereira LM, Scharp LA, et al. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2015;122:746–758.
  • Shimizu K, Toda Y, Iwasaki T, et al. Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial. J Anesth. 2011;25:823–830.
  • Faraoni D, Willems A, Melot C, et al. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2012;42:781–786.
  • Deneux-Tharaux C, Saucedo M. Epidemiology of maternal mortality in France, 2010–2012. Gynecol Obstet Fertil Senol. 2017;45:S8–S21.
  • Ker K, Roberts I, Chaudhri R, et al. WOMAN-2 trial collaborators. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Trials. 2018;19:712.
  • [cited 2019 Jul 24]. Available from: https://clinicaltrials.gov/ct2/show/NCT03431805?term=sentilhes&rank
  • Ducloy-Bouthors AS, Jeanpierre E, Saidi I, et al. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. Trials. 2018;19:149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.